reviewTop 1% cited
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
European Journal of Cancer · 2010 · Vol. 47(1) · pp. 8–32
Matti Aapro✉(Clinique de Genolier)Julia Bohlius(Institute of Social and Preventive Medicine)David Cameron(University of Edinburgh)Lissandra Dal Lago(European Organisation for Research and Treatment of Cancer)J. Peter Donnelly(Radboud University Nijmegen)Nora Kearney(University of Dundee)Gary H. Lyman(Duke University)Ruth Pettengell(University of London)Vivianne C. G. Tjan‐Heijnen(Maastricht University Medical Centre)Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology)Damien C. Weber(University Hospital of Geneva)C. Zielinski(Medical University of Vienna)
Neutropenia and Cancer InfectionsBlood disorders and treatmentsChemotherapy-related skin toxicityMedicinePegfilgrastimFebrile neutropeniaFilgrastimChemotherapyNeutropeniaGranulocyte colony-stimulating factorInternal medicineIntensive care medicineOncology
MeSH terms
AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleFeverHumansLymphoproliferative DisordersMaleNeoplasmsNeutropeniaRecombinant ProteinsRisk FactorsGranulocyte Colony-Stimulating FactorPractice Guidelines as Topic
Citations
1,070
FWCI
28.32
field-weighted impact
References
261
Percentile
100%
vs. same field & year
Citations per year
Cited by
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology · 2012 · 1,518 citations
References
The National Comprehensive Cancer Network
Cancer · 1998 · 16,869 citations
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
European Journal of Cancer · 1993 · 545 citations
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Cancer · 2006 · 1,170 citations
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Journal of Clinical Oncology · 2006 · 1,929 citations
A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer
JNCI Journal of the National Cancer Institute · 2003 · 1,126 citations
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
New England Journal of Medicine · 2004 · 10,930 citations
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
Clinical Infectious Diseases · 2002 · 1,972 citations
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
European Journal of Cancer · 2006 · 535 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.